Low-dose atropine 0.01% for the treatment of childhood myopia: a pan-India multicentric retrospective study.

OBJECTIVE: The objective of this study was to assess the efficacy of low-dose atropine 0.01% in controlling myopia progression among Indian children over a 2-year period. METHODS: This retrospective study, conducted across 20 centres in India, monitored the progression of myopia over 2 years after initiating treatment with 0.01% atropine eye drops. This included children between 6 and 14 years with baseline myopia ranging from -0.5 D to -6 D, astigmatism≤-1.5 D, anisometropia ≤ -1 D and documented myopia progression of ≥0.5 D in the year prior to starting atropine. Subjects with any other ocular pathologies were excluded. RESULTS: A total of 732 children were included in the data analysis. The mean age of the subjects was 9.3±2.7 years. The mean myopia progression at baseline (1 year before starting atropine) was -0.75±0.31 D. The rate of myopia progression was higher in younger subjects and those with higher baseline myopic error. After initiating atropine, myopia progression significantly decreased to -0.27±0.14 D at the end of the first year and -0.24±0.15 D at the end of the second year (p<0.001). Younger children (p<0.001) and higher baseline myopia (p<0.001) was associated with greater myopia progression and poor treatment response (p<0.001 for both). CONCLUSION: Low-dose atropine (0.01%) effectively reduces myopia progression over 2 years in Indian children.

Inert 37-Year-Old Intrastromal Corneal Graphite From Penetrating Ocular Trauma: A Case Report.

Ocular trauma is the most frequent cause of monocular blindness. Ocular surface injury is the commonest among ocular injuries. Corneal abrasion and foreign body are the most common corneal injuries. A 40-year-old dentist with a history of partially penetrating corneal injury due to a pencil presented with and retained graphite bodies in the cornea 37 years after injury. His refraction was +1.0 sphere with no astigmatic error. There was no evidence of any inflammatory reaction. Intrastromal corneal graphite particles can be inert and cause no inflammatory reaction or astigmatic error even decades after injury.

Retinal oximetry in normal and amblyopic children: a pilot study.

PURPOSE: To study the retinal vascular oxygen saturation in amblyopic eyes and compare them to unaffected fellow eyes and eyes of normal subjects. METHODS: A total of 32 amblyopic, 24 normal and 13 fellow eyes of patients below age of 18 were enrolled in this prospective observation study. Retinal oximetry was performed using the Oxymap T1 retinal oximeter. Retinal vascular oxygen saturations and diameters were compared between amblyopic eyes, normal eyes and unaffected fellow eyes. RESULTS: The average age was 8.6 years in the amblyopia group (M:F 16:16) and 10.9 years in the normal group (M:F 7:5; p = 0.024). Median corrected distance visual acuity in the amblyopia group was 20/50; it was 20/20 in the other groups (p < 0.001). The average arteriolar and venous saturation in the amblyopia, normal and fellow group was 84.5% (95% CI: 82.6-86.4), 83.2% (95% CI: 80.7-85.6) and 80.8% (95% CI: 78.6-82.9) and 51.9% (95% CI: 50.4-53.4), 50.8% (95% CI: 48.2-53.4) and 49.3% (95% CI: 45.7-52.9). There was no statistically significant difference between the saturation values of the amblyopia group and the controls, however, significantly higher values were found in the amblyopia group compared to the fellow group for arteriolar and venous saturations (p = 0.013; p = 0.005). Arteriolar and venous diameters showed no significant difference between groups. CONCLUSION: Amblyopic eyes showed higher mean oxygen saturations than the fellow eyes. This observation could be due to altered neuronal activity or could be due to a measurement artefact due to alterations in retinal reflectivity.

Diagnosis and management of primary congenital lens cyst.

We report the case of a 2-year-old girl with an unusual unilateral congenital cystic lesion of the crystalline lens in the right eye. We describe the clinical features, ultrasound biomicroscopy, hypothesis for the possible origin of the cyst, and management of this rare and previously undescribed developmental anomaly.

Anticonvulsant activity of aqueous root extract of Ficus religiosa.

ETHNOPHARMACOLOGICAL RELEVANCE: Ficus religiosa Linn is frequently used for the treatment of nervous disorders among Pawara tribe of the Satpuda range, India. AIM OF THE STUDY: This study aimed to investigate the anticonvulsant activity of the aqueous aerial root extract of Ficus religiosa in chemoconvulsant-induced seizures in mice. MATERIALS AND METHODS: The anticonvulsant activity of the extract (25, 50 and 100 mg/kg, p.o.) was investigated in strychnine-, pentylenetetrazole-, picrotoxin- and isoniazid-induced seizures in mice. Rat ileum and fundus strip preparations were used to study the effect of the extract on acetylcholine (Ach)- and serotonin (5-HT)-induced contractions, respectively. RESULTS: The extract showed no toxicity and protected the animals in the strychnine and pentylenetetrazole tests in a dose-dependent manner. Its effect in the picrotoxin and isoniazid tests, however, was less potent. The extract also exhibited dose-dependent potentiation of Ach in rat ileum but failed to potentiate the effect of 5-HT in rat fundus strip preparation. CONCLUSIONS: The results suggest that an orally administered aqueous root extract of Ficus religiosa has dose-dependent and potent anticonvulsant activities against strychnine- and pentylenetetrazole-induced seizures. The observed activities may be ascribed to the appreciable content of zinc and magnesium in the extract.